HomeOpen Access News

Open Access News

UK laser facility reveals upgrade with £17 million investment

The UK’s Central Laser Facility (CLF), operated by the Science and Technology Facilities Council (STFC), has achieved a primary target through the ultra-infrared laser system.

Building Vaccine Confidence: Strategies for dispelling myths and misinformation

Heidi J Larson, along with contributors from the Vaccine Confidence Project, discuss the complex factors influencing decision-making around vaccines and what can be done to improve public trust.

Utilising frameworks to leverage the best hybrid communication suppliers

Nicki Newburn from, CFH Docmail Ltd, highlights utilising frameworks to leverage the best hybrid communication suppliers.

Is renewable energy killing our birds?

As concerns about the declining bird population continue to grow, scientists highlight the unintentional consequences of renewable energy development.

Researchers identify missing component in Venus’ clouds

Researchers may have cracked the long-standing mystery surrounding the colour and splotchiness of Venusian clouds in the UV range.

Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care

Despite the growing burden of mental health problems, there remains a significant unmet medical need. Tadeusz Hawrot, Founder and Executive Director at Parea tells us why new treatments are urgently needed and how psychedelic therapy and medicines can help

Engineering skills for the climate emergency

It’s not too late to respond to the challenges of the climate emergency – but only if we fast-track vital engineering skills into our economy before 2030 – The Royal Academy of Engineering explains.

Anti Money laundering: What the UK’s AML consultation means for compliance professionals

Money laundering is a formidable threat to the UK economy, with an annual cost estimated at £100 billion. To address the problem, the government has unveiled a £400 million three-year Economic Crime Plan, aiming to fill gaps in fraud, anti-money laundering (AML) and more.

Declining honey yields in the U.S. linked to herbicides

In the last few decades, honey yields in the United States have steadily declined since the 1990s, leaving honey producers and scientists looking for answers.

Breaking the stigma: Men’s mental health matters

Dr Deborah Lee from Dr Fox Online Pharmacy discusses men’s mental health, including common barriers to seeking help and the measures needed to improve overall awareness and support.

Potential link between IDO2 gene and autism spectrum disorder

Researchers investigate indoleamine 2,3-dioxygenase 2 (IDO2), an enzyme expressed in the brain, to shed light on its potential role in autism spectrum disorder (ASD).

Hydrogen refuelling station at new dimensions

Dr. Stefan Rehm, Managing Director of Hypion GmbH, presents the logic of integrated hydrogen hubs as concept to decarbonise heavy duty road transportation.

Human progress may delay global environmental solutions

Insights into the central features of human evolution may divert efforts to address environmental problems, including climate change.

Secarna aims to expand the therapeutic toolbox against cancer

Current oncology treatments have significantly improved cancer survival rates, but more effective and safer therapeutics are needed.

Providing the digital energy ecosystem for the energy transition

Amp X is an innovative digital energy platform using a unique, whole-system approach to address critical issues that exist in the electricity grid as a result of the ongoing energy transition towards a fully decarbonised future.

Combining mindfulness and exercise for a happier 2024

Many seek ways to improve their physical and mental well-being as the New Year begins; but how can mindfulness give you the motivation you need to exercise.

Secarna: Next generation antisense therapeutics

Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders